(Q34583900)

3 August 2017

1 reference

title

Proteasome inhibition: a novel approach to cancer therapy (English)

1 reference

3 August 2017

Julian Adams

1

1 reference

3 August 2017

1 January 2002

1 reference

Trends in Molecular Medicine

3 August 2017

1 reference

3 August 2017

8

1 reference

3 August 2017

S49-54

1 reference

3 August 2017

4 Suppl

1 reference

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Proteasome inhibition: a new strategy in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

New insights into role of microenvironment in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902315-8

7 January 2021

10.1016/S1471-4914(02)02315-8

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11927288